THE DEVICE: Remote-control insulin pump
WHAT IT WILL DO Allow booming numbers of diabetes patients, especially children, to have insulin and glucose levels managed remotely via data sent to a physician or parent. Controlling glucose levels is key to preventing life-threatening complications; it also saves insurers money.
WHO'S DEVELOPING IT: Johnson & Johnson (JNJ), Medtronic (MDT), Roche
 Meet the companies tackling nine of humanity's biggest problems -- and making millions saving us from ourselves. (more)  As consumers take charge of their health care, opportunities abound for businesses that bring power to the people. (more)  The year's biggest boors, buffoons and blunderers. See the winners, watch the video, and test your Dumbest knowledge. (more) |
